ArticleCancer letters2025

Preserved host immunity with intercellular adhesion molecule-1 (ICAM-1)-targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of triple-negative breast cancer and other malignancies.

Seiichiro Takao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.